Physician profile
Paul D Wilson
NPI 1710067277
$455.48
in general payments reported to CMS, 2019-2025
7 companies · $69.83 in 2025
The $69.83 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.62 · 2020: $20.51 · 2021: $58.27 · 2022: $30.95 · 2023: $128 · 2024: $115 · 2025: $69.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270 · Entertainment: $43.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.87 |
| Entertainment | $43.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $179.81 | 2020-2025 | Acuvue |
| Alcon Vision LLC | $93.38 | 2023-2025 | Precision 1, Precision7, Total30 |
| Coopervision INC. | $75.21 | 2019-2024 | Myday Contact Lens |
| Optos, INC. | $43.26 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $25.85 | 2023 | Tyrvaya |
| Plexus Optix, INC. | $19.55 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.